Big Bets and Strategic Moves Drive Biotech Investment in 2025 10 months ago ByJohnIn InvestmentsLeadersPartnerships
Laquinimod Eye Drops Show Safety and Penetration in Phase I LION Trial 10 months ago ByJohnIn Clinical TrialsTop Stories
Emerging Clinical Research Highlights Innovation and Regulatory Progress 10 months ago ByJohnIn Clinical TrialsDeals
Phase II Trial of Novel Radiopharmaceutical NeoB-GRP Shows Early Promise in Prostate Cancer 10 months ago ByJohnIn Biopharma HighlightsTop Stories
TrialMatchAI Demonstrates Strong Patient-to-Trial Matching Capabilities for Oncology Studies 10 months ago ByJohnIn AI & DataClinical Trials
Vera Therapeutics and Minovia Push Forward in Clinical Development 10 months ago ByJohnIn Research UpdatesTop Stories
AC Immune and Edgewise Therapeutics Report Promising Clinical Progress 10 months ago ByJohnIn BreakthroughsClinical Trials
MAIA Biotechnology Sets Its Sights on Bold Cancer Immunotherapy Milestones for 2025 11 months ago ByJohnIn Breaking NewsFDA ApprovalsLeadersResearch UpdatesTop Stories
MaaT Pharma Presents Promising Preclinical Data for Next-Gen Microbiome Therapy MaaT034 at AACR 11 months ago ByJohnIn Biopharma HighlightsClinical TrialsFunding RoundsInnovation
Gene-Silencing Therapy Lepodisiran Shows Major Reduction in Lipoprotein(a); Spinogenix Opens Phase 2 Schizophrenia Trial 11 months ago ByJohnIn Biopharma HighlightsClinical TrialsInnovationResearch Updates
FDA Leadership Change Sparks Industry Concern as Pharma Navigates Regulatory Challenges 11 months ago ByJohnIn Biopharma HighlightsInnovationLeadersPharma Industry Updates
FDA Approves Fitusiran for Hemophilia A and B; Vertex Halts VX-264 Type 1 Diabetes Trial 11 months ago ByJohnIn Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
FDA Approves Fitusiran (Qfitlia) – First RNAi Therapeutic for Hemophilia A and B; Vertex Halts VX-264 T1D Trial 11 months ago ByJohnIn Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
MaaT Pharma Completes €13 Million Capital Increase; Highlights 2024 Progress and 2025 Growth Plans 11 months ago ByJohnIn Biopharma HighlightsClinical TrialsFunding RoundsInnovationPharma Industry Updates
Viking Therapeutics Reports Full Enrollment in Phase 2 Oral Obesity Drug Trial; Bluejay Therapeutics Advances in Neurological Research 11 months ago ByJohnIn Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
